Peritoneal absorption of moxalactam.
We evaluated the rate and extent of the systemic absorption of moxalactam given intraperitoneally to patients with peritonitis and end-stage renal disease who were being maintained on continuous ambulatory peritoneal dialysis. Moxalactam was administered at a concentration of 200 mg per 2-liter dial...
Gespeichert in:
| Veröffentlicht in: | Antimicrob Agents Chemother |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
1983
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185101/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6625555/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.24.1.39 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|